Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases
Clinical trial NCT07444606 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07444606
- Sponsor
- M.D. Anderson Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2027-01-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.